References
- Mellin GW, The saga of thalidomide. N Engl J Med (1962) 267: 1184–93.
- Mellin GW, The saga of thalidomide (concluded). N Engl J Med (1962) 267: 1238–44.
- Wines N, Cooper A, Wines M, Thalidomide in dermatol- ogy. Australas J Dermatol (2002) 43: 229–40.
- Bec¸het PE, Hypertrophic lupus erythematosus. Arch Derm Syph (1940) 42: 211–20.
- John MD, Gruber GG, Turner JE et al, Lupus erythema- tosus hypertrophicus. Cutis (1981) 28: 290–2.
- Santa Cruz DJ, Uitto J, Eizen AZ et al, Verrucous lupus erythematosus: ultrastructural studies on a distinct variant of chronic discoid lupus erythematosus. J Am Acad Dermatol (1983) 9: 82–90.
- Rubenstein DJ, Huntley AC, Keratotic lupus erythema- tosus: treatment with isotretinoin. J Am Acad Dermatol (1986) 14: 910–14.
- Knop J, Bonsmann G, Happle R et al, Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol (1983) 108: 461–6.
- Duong DJ, Spigel GT, Moxley RT, Gaspari AA, American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus. Arch Dermatol (1999) 135: 1079–87.
- Kyriakis KP, Kontochristopoulos GJ, Panteleos DN, Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus. Int J Dermatol (2000) 39: 218–22.
- Housman TS, Jorizzo JL, McCarty MA et al, Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch Dermatol (2003) 139: 50–4.
- Thomson KF, Goodfield MJ, Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus. J Dermatolog Treat (2001) 12: 145–7.
- Moraes M, Russo G, Thalidomide and its dermatologic uses. Am J Med Sci (2001) 321: 321–6.
- Ordi-Ros J, Cortes F, Cucurull E et al, Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. J Rheumatol (2000) 27: 1429–33.
- Bohmeyer J, Achenbach A, Westenberger M et al, Thalidomide therapy of cutaneous lupus erythematosus. Hautarzt (2002) 53: 744–8.
- Georgala S, Katoulis AC, Hasapi V, Koumantaki- Mathioudaki E, Thalidomide treatment for hypertrophic lupus erythematosus. Clin Exp Dermatol (1998) 23: 141.